| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 07/08/2004 | WO2004056763A2 Novel glucagon antagonists |
| 07/08/2004 | WO2004056745A2 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004056744A1 Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors |
| 07/08/2004 | WO2004017920A3 Novel biphenyl and biphenyl-like cannabinoids |
| 07/08/2004 | WO2003103599A3 Caspase-1 inhibitors and methods for their use |
| 07/08/2004 | US20040133013 Novel polyamine analog-amino acid conjugates useful as anticancer agents |
| 07/08/2004 | US20040132782 Aspartyl protease inhibitors |
| 07/08/2004 | US20040132722 Glycoprotein-mediated MDR |
| 07/08/2004 | US20040132694 6-Chloro-3-(3,4-dioxo-2-phenylamino-cyclobut-1-enylamino)-2-hydroxy-benzamide; psoriasis, atopic dermatitis, arthritis, asthma, chronic obstructive pulmonary disease, adult respiratory distress syndrome, inflammatory bowel disease, Crohn's disease |
| 07/08/2004 | US20040131544 Positron emission tomography ; multistage process; medical diagnosis |
| 07/08/2004 | CA2508621A1 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 07/07/2004 | EP1435352A2 9-[(Substituted glycyl)amido]-6-(substituted)-5-hydroxy-6-deoxytetracyclines |
| 07/07/2004 | CN1511137A Hydro phobic polyamine analogs and methods for their use |
| 07/06/2004 | US6759555 Process for the preparation of combretastatins |
| 07/06/2004 | US6759554 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/06/2004 | US6759433 Acetamidobenzamide compounds for neurodegenerative disorders |
| 07/06/2004 | US6759412 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis |
| 07/06/2004 | US6759406 Quaternary ammonium compounds |
| 07/01/2004 | WO2004018644A3 HETEROGENEOUS FOLDAMERS CONTAINING α, β, AND/OR Ϝ-AMINO ACIDS |
| 07/01/2004 | WO2004005513A3 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 07/01/2004 | WO2003045878A8 2,w-diaminocarboxylic acid compounds |
| 07/01/2004 | WO2002100341A3 Compounds for the treatment of metabolic disorders |
| 07/01/2004 | US20040127747 using as alkylating agents organic carbonates, preferably of the dialkyl, dibenzyl and diallyl types, in the presence of X- or Y-faujasite catalysts exchanged with alkaline metals |
| 07/01/2004 | US20040127664 Adhesives and sealants |
| 07/01/2004 | US20040127574 Aminoethanol derivatives |
| 07/01/2004 | US20040127565 Quarternary ammonium compounds |
| 07/01/2004 | US20040127555 bis- and tris-dihydroxyaryl compounds and their methylenedioxy analogs; treatment of A beta , IAPP, other amyloids, and alpha -synuclein or NAC fibrillogenesis |
| 07/01/2004 | US20040127494 Sulfur compounds such as (2R)-2-[N-(4-Chlorobenzenesulfonyl)-N-(4-methoxybenzyl)amino]-4-methylpentanoic acid amide, used for prophylaxis of neurodegenarative disorders such as Alzheimer's Disease and Down's Syndrome |
| 06/30/2004 | EP1173413B1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors |
| 06/29/2004 | US6756365 Reducing tetracycline resistance in living cells |
| 06/29/2004 | US6756047 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/24/2004 | WO2004052939A2 Ligands for metals and improved metal-catalyzed processes based thereon |
| 06/24/2004 | WO2004052846A1 Tetrahydro-naphthalene derivatives |
| 06/24/2004 | WO2004052840A1 Compounds which modulate pparϝ type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/24/2004 | WO2004052838A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | WO2004052837A2 Amino substituted hydroxyphenyl benzophenone derivatives |
| 06/24/2004 | WO2004039320A3 STEREOISOMERS OF p-HYDROXY-MILNACIPRAN, AND METHODS OF USE THEREOF |
| 06/24/2004 | US20040122004 such as (1R,2R)-N-[(1S)-2-amino-1-(4-fluorophenyl)-2-oxoethyl]-2-(4-{[{[ethyl(2-hydroxyethyl)amino]carbonyl}(4-fluorophenyl)amino]methyl}phenyl)cyclohexanecarboxamide; for prevention/treatment of cardiovascular disorders |
| 06/24/2004 | US20040121962 Prodrugs of excitatory amino acids |
| 06/24/2004 | US20040121941 Novel inhibitors of prenylated pyrophosphate consuming enzymes |
| 06/24/2004 | CA2507137A1 Arylene-carboxylic acid (2-amino-phenyl)-amide derivatives as pharmaceutical agents |
| 06/24/2004 | CA2506732A1 Compounds which modulate ppar.gamma. type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/23/2004 | EP1431274A1 Synthesis of mono-N-substituted functionalized anilines |
| 06/23/2004 | EP1430020A1 Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them |
| 06/23/2004 | EP1430018A1 Method for producing beta-alanine amides |
| 06/23/2004 | EP1429765A2 Inhibitors of histone deacetylase |
| 06/22/2004 | US6753327 Neurodegenerative disorder or neuronal damage treatment; inhibitors of calpain or cathepsin cysteine proteases; antiischemic agents; reperfusion injuries |
| 06/22/2004 | CA2135491C Process for preparing substituted aromatic amines |
| 06/17/2004 | WO2004050613A2 2-substituted-3-propenamide derivatives and methods of using the same |
| 06/17/2004 | WO2004037769A3 Cycloalkylamides and their therapeutic use as antiepileptic and anticonvulsant |
| 06/17/2004 | US20040116654 Isolated polypeptides; genetic engineering; quantitative analysis |
| 06/17/2004 | US20040116507 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 06/17/2004 | US20040116439 Serine protease inhibitors |
| 06/17/2004 | US20040116355 Caspase inhibitors and the use thereof |
| 06/17/2004 | US20040116353 Derivatives of n-(arylsulfonyl)beta-aminoacids comprising a substituted aminomethyl group, the preparation method thereof and the pharmaceutical compositions containing same |
| 06/17/2004 | US20040115732 Combinatorial libraries of autoinducer analogs, autoinducer agonists and antagonists, and methods of use thereof |
| 06/16/2004 | EP1427705A2 Insecticidal diamides |
| 06/16/2004 | EP1427424A2 Lpa receptor agonists and antagonists and methods of use |
| 06/16/2004 | EP1089963B1 Hydroxamic acid derivatives as inhibitors of the production of human cd23 and of the tnf release |
| 06/16/2004 | CN1505609A Compound useful as intermediates for cholesteryl ester transfer protein (CETP) inhibitors |
| 06/16/2004 | CN1153759C Novel delta-amino-gamma-hydroxy-omega-aryl-alkane amide compounds |
| 06/16/2004 | CN1153568C Compounds active at a novel position on receptor-operated calcium channel useful for treatment of neurological disorders |
| 06/15/2004 | US6750369 Substituted amino acids as erythropoietin mimetics |
| 06/15/2004 | US6750255 Calcium receptor-active compounds |
| 06/15/2004 | US6750244 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/15/2004 | US6750238 Aralkyl ester soft drugs |
| 06/15/2004 | US6750236 Cardiovascular disorders |
| 06/10/2004 | WO2004048319A1 Novel benzamide compounds for use in mch receptor related disorders |
| 06/10/2004 | WO2004047615A2 Hemiasterlin affinity probes and their uses |
| 06/10/2004 | US20040110959 Antiangiogenic drug to treat cancer, arthritis and retinopathy |
| 06/10/2004 | US20040110839 Compounds and compositions for delivering active agents |
| 06/10/2004 | US20040110832 management, treatment and/or control of diseases caused in intrinsic clotting pathway utilizing factor IX such as stroke, myocardial infarction, aneurysm surgery, and deep vein thrombosis associated with surgical procedures etc |
| 06/10/2004 | US20040110753 Tyrosine derivatives |
| 06/10/2004 | US20040110736 Cyclic derivatives as modulators of chemokine receptor activity |
| 06/10/2004 | US20040110728 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 06/10/2004 | US20040110692 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 06/10/2004 | US20040110303 Artificial receptors, building blocks, and methods |
| 06/09/2004 | EP1426356A1 Intermediate compounds for the preparation of mirtazapine and the production methods thereof |
| 06/09/2004 | EP1426353A1 1,3-minus;GLYCERIDE COMPOUND HAVING TWO IODOPHENYL GROUPS |
| 06/09/2004 | EP1425270A2 Methods and intermediates for preparing 4-aminoquinoline cetp inhibitors |
| 06/09/2004 | EP1425001A1 Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/09/2004 | EP1154986B1 Process for the preparation of iopamidol |
| 06/09/2004 | EP1019364B1 Inhibitors of protein tyrosine phosphatase |
| 06/09/2004 | CN1152854C Preparation of tri-iodo benzene compound |
| 06/08/2004 | US6747143 Methods for polymer synthesis |
| 06/08/2004 | US6747047 Arthropodicides |
| 06/08/2004 | CA2102490C 2-amino-1,2,3,4-tetrahydronaphthalene derivatives active on the cardiovascular system, processes for their preparation and pharmaceutical compositions containing them |
| 06/08/2004 | CA2079692C Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines |
| 06/03/2004 | WO2004046091A2 Biaromatic compounds which activate ppar-gama type receptors, and use thereof in cosmetic or pharmaceutical compositions |
| 06/03/2004 | WO2004045536A2 Method and compositions for temporarily incapaciting subjets |
| 06/03/2004 | WO2004045533A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/03/2004 | US20040106828 Heating, refluxing using 2-methoxypropanol; contrast agent for x-ray diagnosis |
| 06/03/2004 | US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 06/03/2004 | US20040106792 Biphenyl compound |
| 06/03/2004 | US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent |
| 06/03/2004 | US20040106560 such as N1-L-Arginylspermidine for protecting from damage from extended ischemic/hypoxic events |
| 06/03/2004 | US20040103820 To enhance light resistance by absorbing ultraviolet (UV) light, provide wettability and stabilize a colorant |
| 06/03/2004 | CA2503316A1 Method and compositions for temporarily incapacitating subjects |
| 06/03/2004 | CA2503312A1 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs |
| 06/02/2004 | EP1091929B1 Secondary aspartic acid amide esters |